China innovation as bio-tech, pharma hub: Novo Holdings CEO

China has identified key areas with potential to drive new quality productive forces. These involve strategic economic and industrial shifts away from traditional labor- and capital-intensive industries toward innovation-driven, high-tech and sustainable enterprises. Bio-manufacturing is high on the agenda. China's cooperation with key international players in the field is stronger than ever, supported by the country's innovation capabilities. On this and more, hear from Kasim Kutay, CEO of Novo Holdings, the controlling shareholder of Novo Nordisk. 00:00 - Intro 00:46 - China is an innovation hub for biotech, life sciences 06:10 - How can pharma companies adapt to geopolitical risks 08:34 - Top challenges for the pharma industry as it shifts from treatment to prevention 12:09 - AI seems to boost drug discovery and development 📺 Subscribe to our YouTube channel and stay updated with our latest analysis and interviews:👇 https://www.youtube.com/channel/UCgrNz-aDmcr2uuto8_DL2jg 👈 Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8 Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv For more: https://www.cgtn.com/video Most watched videos: Impossible Challenge: 30 seconds to count banknotes BLINDFOLDED https://www.youtube.com/watch?v=ZmP_Ybj-jws Impossible Challenge: Gymnastics Boy Arat Hosseini from Iran! https://www.youtube.com/watch?v=8sxX--U4c8w Impossible Challenge: How to calm babies in 5 seconds? https://www.youtube.com/watch?v=kR3q9sXM7WA